Allergenis, with a valuation of $40 million, is raising funds on StartEngine. The company uses cutting-edge systems biology and data analytics to provide next-generation food allergy testing. The Allergenis system of testing determines tolerance levels, allergic status, and reaction severity to provide a better-informed quality of life. Currently, Allergenis provides peanut allergic status and threshold testing in 49 states and Washington, DC, and plans to launch milk allergy testing in 2023 and egg allergy testing in 2024. Jim Garner founded Allergenis in September 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1.24 million. The campaign proceeds will be used for sales and marketing, clinical operations, research and development, and general and administrative expenses.